Code : 9345-346842      Created Date : Tuesday, May 19, 2015   Update Date : Tuesday, May 19, 2015    Visit : 1509

ICAR2014

The report of ICAR2014 by Dr. Jamal Hashemi
 
Application Code :
306-0214-0129
 
Created Date : Sunday, November 2, 2014 11:39:13Update Date : Saturday, January 10, 2015 12:55:08
IP Address : 194.225.57.25Submit Date : Saturday, January 10, 2015 12:58:14Email : sjhashemi@tums.ac.ir
Personal Information
Name : Jamal
Surname : Hashemi
School/Research center : School of Public Health
If you choose other, please name your Research center :  
Position : Professor
Tel : +98-21-88252255
Information of Congress
Title of the Congress : ICAR2014
Title of your Abstract : Susceptibility of Aspergillus species isolated from cutaneous and visceral lesions to conventional antifungal drugs in
country : Spain
From : Wednesday, October 1, 2014
To : Friday, October 3, 2014
Abstract(Please copy/paste the abstract send to the congress) : Background :Different studies have shown, despite the expanding antifungal agents, opportunistic fungal infections death incidence rate caused by species of Aspergillus have increased during recent decades due to the growth of potential factors and immunosuppressed individuals.
Susceptibility decrease, drug-resistance occurrence, MIC (Minimum Inhibitory Concentration) increase, and cross resistance among the isolated Aspergillus SPP., lack of effective response to conventional treatments, inaccessibility of the antifungal susceptibility patterns of the most common Iranian isolated Aspergillus SPP. have become an excuse to design and carry out the present study. It is important to remember that the rude mortality from invasive Aspergillosis is around 85% and falls to around 50% if treated more precisely. 
Methodology: During 13 months 50 clinically isolated Aspergillus, which have been isolated from viseral and cutaneous samples, based on Klich 2002 method and the morphological features were devided into 40 strains of A. flavus, 9 strains of A. niger, and one strain of A. fumigatus. Then their susceptibility test was carried out according to the standard method of NCCLS – M38A Broth Microdilution.
Results: Through this study we found out that 7.5% of the isolated A. flavus with MIC > 2µg/ml in relation to AMB medicine, according to CSLI Guideline are probably considered to be as clinically resistant isolated types or treatment failures, and 25% of them in relation to ITR medicine with MIC = 1 µg/ml and by MIC < 8 µg/ml are considered to be as less sensitive isolated species. On the whole, the domestic isolated A. flavus species were less sensitive than those which have been under studies overseas. 
The MIC range of 9 strain A. niger in relation to AMB, ITR, VRC medicines respectively came out 0.5 – 1 µg/ml, 0.5 – 2µg/ml, and 0.25 – 2µg/ml, that in comparison with similar foreign studies had less sensitivity in spite of being in the standard strain of MIC range and protocol.
The MIC range of 1 strain A. niger in relation to AMB, ITR, VRC medicines respectively came out 1, 2, and 0.25 MIC µg/ml, that according to CLSI protocol are considered as high. In comparison with similar foreign studies had less sensitivity.
Conclusion: Through this study we found out that the MIC range Iranian Aspergillus isolated from clinical specimens in the majority of the cases go into the reference standard strains of MIC range and the MIC range of some foreign studies. But in some important cases go out of this range that shows lower sensitivity of Iranian isolated Aspergillus and their MIC increase. 
Keywords: Aapergillus, Drug resistance, MIC, Amphotericin B, Itracunazole ,Voricunazole ,Cross resistance
Keywords of your Abstract : , Itracunazole ,Voricunazole ,Amphotericin B,
Acceptance Letter :
The presentation : Poster
The Cover of Abstract book :
Published abstract in the abstract book with the related code : http://gsia.tums.ac.ir/images/UserFiles/22147/Forms/306/38.pdf
Where has your abstract been indexed? : ISI
If you choose other, please name :  
The Congress Reporting Form
How many volunteers were present at the Congress? : 450 persons
Delegates from which countries presented in the congress? : 60 countries: Iran/Germany /Portugal/ USA/ Japan/Canada and the other country
Were the delegates of any other organizations present in the congress? : No
If yes, please write the names of the organizations in the box :  
What were the responses to your talking points? Were specific questions or concerns raised? : I had a poster as title The susceptibility of Aspergillus spp isolated from cutaneous and visceral lesions to antifungal drugs in Iran, and the main question was based on species of Aspergillus
If you met staff members, please list their full names & positions. : I was the only participant from TUMS
Please inform us if there are any follow up actions we need to talk with the members of the congress : 1-Pay attention to sanctions request the congress team for on site registration
2- The registration fee usually is so much it is better talk to member of congress for discount 
3- Inform the Iranian volunteers as soon as possible about decision for article submission because visa taking waste a long time
4- Talking about invitation letter that was done as soon as possible
Your experiences about the travel processes(Providing ticket, accommodation,...) : Every things was difficult
Please give a briefing of your own observations and outcomes of the congress: : This congress was about drug and drug resistance and it was novel for me because it was the first time that I attended in a pharmacological congress.
1-Many new drugs were introduce for the first time for bacteria viral fungi and the other microorganism
2-Many papers were about drug resistance, an import subject that lead to many investigation for finding and solving and breaking the microorganism resistance
3-Introduce of the plants for the production of new drugs was another item that was important. Finding the drugs with minimum side effect with planetary source is another approach for finding a good treatment.

 

Your Comments :
captcha
Close